269 related articles for article (PubMed ID: 17108040)
1. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
Yue Y; Kaur A; Eberhardt MK; Kassis N; Zhou SS; Tarantal AF; Barry PA
J Virol; 2007 Feb; 81(3):1095-109. PubMed ID: 17108040
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
Yue Y; Zhou SS; Barry PA
J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
[TBL] [Abstract][Full Text] [Related]
3. A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.
Abel K; Strelow L; Yue Y; Eberhardt MK; Schmidt KA; Barry PA
Vaccine; 2008 Nov; 26(47):6013-25. PubMed ID: 18760319
[TBL] [Abstract][Full Text] [Related]
4. Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
Eberhardt MK; Deshpande A; Fike J; Short R; Schmidt KA; Blozis SA; Walter MR; Barry PA
J Virol; 2016 Nov; 90(21):9920-9930. PubMed ID: 27558431
[TBL] [Abstract][Full Text] [Related]
5. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
Yue Y; Kaur A; Zhou SS; Barry PA
J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.
Abel K; Martinez J; Yue Y; Lacey SF; Wang Z; Strelow L; Dasgupta A; Li Z; Schmidt KA; Oxford KL; Assaf B; Longmate JA; Diamond DJ; Barry PA
J Virol; 2011 Mar; 85(6):2878-90. PubMed ID: 21191005
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model.
Valencia S; Gill RB; Dowdell KC; Wang Y; Hornung R; Bowman JJ; Lacayo JC; Cohen JI
Vaccine; 2019 Jan; 37(2):333-342. PubMed ID: 30522906
[TBL] [Abstract][Full Text] [Related]
8. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.
Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E
Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
10. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
12. Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
Eberhardt MK; Chang WL; Logsdon NJ; Yue Y; Walter MR; Barry PA
PLoS One; 2012; 7(5):e37931. PubMed ID: 22655082
[TBL] [Abstract][Full Text] [Related]
13. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.
Yue Y; Chang WLW; Li J; Nguyen N; Schmidt KA; Dormitzer PR; Yang X; Barry PA
J Virol; 2022 Feb; 96(3):e0165321. PubMed ID: 34788083
[TBL] [Abstract][Full Text] [Related]
15. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
[TBL] [Abstract][Full Text] [Related]
16. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
Webster H; Valencia S; Kumar A; Chan C; Dennis M; Roark H; Woods A; John S; Carfi A; Permar SR
Vaccine; 2021 Sep; 39(38):5358-5367. PubMed ID: 34393017
[TBL] [Abstract][Full Text] [Related]
17. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques.
Yue Y; Wang Z; Abel K; Li J; Strelow L; Mandarino A; Eberhardt MK; Schmidt KA; Diamond DJ; Barry PA
Med Microbiol Immunol; 2008 Jun; 197(2):117-23. PubMed ID: 18196272
[TBL] [Abstract][Full Text] [Related]
19. Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses.
Li J; Wellnitz S; Chi XS; Yue Y; Schmidt KA; Nguyen N; Chen W; Yurgelonis I; Rojas E; Liu Y; Loschko J; Pollozi E; Matsuka YV; Needle E; Vidunas E; Donald RGK; Moran J; Jansen KU; Dormitzer PR; Barry PA; Yang X
J Infect Dis; 2022 Sep; 226(4):585-594. PubMed ID: 35413121
[TBL] [Abstract][Full Text] [Related]
20. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
